The online version of this article (doi:https://doi.org/10.1186/s12916-017-0989-z) contains supplementary material, which is available to authorized users.
Rotavirus causes severe gastroenteritis in infants and young children worldwide. The UK introduced the monovalent rotavirus vaccine (Rotarix®) in July 2013. Vaccination is free of charge to parents, with two doses delivered at 8 and 12 weeks of age. We evaluated vaccine impact across a health system in relation to socioeconomic deprivation.
We used interrupted time-series analyses to assess changes in monthly health-care attendances in Merseyside, UK, for all ages, from July 2013 to June 2016, compared to predicted counterfactual attendances without vaccination spanning 3–11 years pre-vaccine. Outcome measures included laboratory-confirmed rotavirus gastroenteritis (RVGE) hospitalisations, acute gastroenteritis (AGE) hospitalisations, emergency department (ED) attendances for gastrointestinal conditions and consultations for infectious gastroenteritis at community walk-in centres (WIC) and general practices (GP). All analyses were stratified by age. Hospitalisations were additionally stratified by vaccine uptake and small-area-level socioeconomic deprivation.
The uptake of the first and second doses of rotavirus vaccine was 91.4% (29,108/31,836) and 86.7% (27,594/31,836), respectively. Among children aged < 5 years, the incidence of gastrointestinal disease decreased across all outcomes post-vaccine introduction: 80% (95% confidence interval [CI] 70–87%; p < 0.001) for RVGE hospitalisation, 44% (95% CI 35–53%; p < 0.001) for AGE hospitalisations, 23% (95% CI 11–33%; p < 0.001) for ED, 32% (95% CI 7–50%; p = 0.02) for WIC and 13% (95% CI -3–26%; p = 0.10) for GP. The impact was greatest during the rotavirus season and for vaccine-eligible age groups. In adults aged 65+ years, AGE hospitalisations fell by 25% (95% CI 19–30%; p < 0.001).
The pre-vaccine risk of AGE hospitalisation was highest in the most socioeconomically deprived communities (adjusted incident rate ratio 1.57; 95% CI 1.51–1.64; p < 0.001), as was the risk for non-vaccination (adjusted risk ratio 1.54; 95% CI 1.34–1.75; p < 0.001). The rate of AGE hospitalisations averted per 1,000 first doses of vaccine was higher among infants in the most deprived communities compared to the least deprived in 2014/15 (28; 95% CI 25–31 vs. 15; 95% CI 12–17) and in 2015/16 (26; 95% CI 23–30 vs. 13; 95% CI 11–16).
Following the introduction of rotavirus vaccination, incidence of gastrointestinal disease reduced across the health-care system. Vaccine impact was greatest among the most deprived populations, despite lower vaccine uptake. Prioritising vaccine uptake in socioeconomically deprived communities should give the greatest health benefit in terms of population disease burden.
Additional file 1: Table S1. Yearly rates of hospitalisation/attendance for different levels of the health system pre- and post-rotavirus vaccine introduction in Merseyside, UK. (DOCX 25 kb)12916_2017_989_MOESM1_ESM.docx
Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:136–41. CrossRefPubMed
World Health Organization. Global networks of rotavirus gastroenteritis, 2001–2008. Wkly Epidemiol Rec. 2008;83:421–8.
ROTA Council. Rotavirus deaths & rotavirus vaccine introduction maps – ROTA Council. Global Introduction Status. http://rotacouncil.org/vaccine-introduction/global-introduction-status/. Accessed 16 Nov 2016.
Public Health England. National rotavirus immunisation programme: preliminary data for England, February 2016 to July 2016. Health Prot Rep Wkly Rep. 2016;10:1–6.
Atchison CJ, Stowe J, Andrews N, Collins S, Allen DJ, Nawaz S, et al. Rapid declines in age group–specific rotavirus infection and acute gastroenteritis among vaccinated and unvaccinated individuals within 1 year of rotavirus vaccine introduction in England and Wales. J Infect Dis. 2016;13(2):243–9. doi: https://doi.org/10.1093/infdis/jiv398.
Bawa Z, Elliot AJ, Morbey RA, Ladhani S, Cunliffe NA, O’Brien SJ, et al. Assessing the likely impact of a rotavirus vaccination program in England: the contribution of syndromic surveillance. Clin Infect Dis. 2015;61(1):77–85. doi: https://doi.org/10.1093/cid/civ264.
English indices of deprivation – GOV.UK. https://www.gov.uk/government/collections/english-indices-of-deprivation. Accessed 17 Apr 2014.
Office for National Statistics. Lower super output area mid-year population estimates. 2016. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/lowersuperoutputareamidyearpopulationestimates. Accessed 5 Jul 2017.
Hungerford D, Macpherson P, Farmer S, Ghebrehewet S, Seddon D, Vivancos R, et al. Effect of socioeconomic deprivation on uptake of measles, mumps and rubella vaccination in Liverpool, UK over 16 years: a longitudinal ecological study. Epidemiol Infect. 2016;144(6):1201–11. doi: https://doi.org/10.1017/S0950268815002599.
Department of Health. Information requirements for child health information systems – publications. 2012. https://www.gov.uk/government/publications/information-requirements-for-child-health-information-systems.
Public Health England. Public health functions to be exercised by NHS England Service specification No. 28 Child Health Information Systems (CHIS). London: Department of Health; 2013.
Hungerford D, Vivancos R, EuroRotaNet network members, Read JM, Pitzer VE, Cunliffe N, et al. In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13. Euro Surveill. 2016;21(2). https://doi.org/10.2807/1560-7917.ES.2016.21.2.30106.
Public Health England. Rotavirus: the green book, chapter 27b. 2013. Available from: https://www.gov.uk/government/publications/rotavirus-the-green-book-chapter-27b. Accessed 4 Jul 2017.
World Health Organization Regional Office for Europe. Health 21: the health for all policy framework for the WHO European Region. Report No: 6. Copenhagen, Denmark: World Health Organization Regional Office for Europe; 1999. p. 1–230.
World Health Organization Regional Office for Europe. European vaccine action plan 2015–2020 (2014). Copenhagen, Denmark: World Health Organization Regional Office for Europe; 2014. p. 1–108. http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/2014/european-vaccine-action-plan-20152020–2014.
Hemming M, Räsänen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013;172:739–46. CrossRefPubMed
Tam CC, Viviani L, Adak B, Bolton E, Dodds JP, Cowden JM, et al. The second study of infectious intestinal disease in the community (IID2 study). Manchester, UK: University of Manchester; 2012. https://www.food.gov.uk/science/research/foodborneillness/b14programme/b14projlist/b18021.
Muhsen K, Chodick G, Goren S, Anis E, Ziv-Baran T, Shalev V, et al. Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel. Euro Surveill. 2015;20(42). https://doi.org/10.2807/1560-7917.ES.2015.20.42.30045.
Muhsen K, Chodick G, Goren S, Shalev V, Cohen D. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community. Vaccine. 2011;29:91–4. CrossRef
Gosselin V, Généreux M, Gagneur A, Petit G. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status. Hum Vaccines Immunother. 2016;12:2572–9. CrossRef
Public Health England. UK standards for microbiology investigations S7: gastroenteritis and diarrhoea. Report No.: 7:1. London: Public Health England; 2013. p. 1–20. https://www.gov.uk/government/publications/smi-s-7-gastroenteritis-and-diarrhoea.
Lambert SB, Faux CE, Hall L, Birrell FA, Peterson KV, Selvey CE, et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust. 2009;191:157–60. PubMed
- Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK
Jonathan M. Read
Nigel A. Cunliffe
- BioMed Central
Neu im Fachgebiet Allgemeinmedizin
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II